Compound repurposing

Filters

Small molecule compounds are being studied for repurposing in COVID-19 treament and research. Multiple small molecules that are approved to treat other disorders have shown potential effects on key proteins involved in SARS-CoV-2 host cell entry and replication. Repurposing of existing compounds is advantageous for speed - reducing timescales compared to conventional drug discovery. Researchers can save up to 50% on these small molecules for COVID-19 research, as they are up to half the price of other suppliers.

3 Items

Set Descending Direction
  1. Gap19 (HB5162)

    Description:

    Cx43 hemichannel blocker

    Purity:

    >95%

    Pack:
    1mg
    Price:
    $155
    Qty:
  2. Description:

    Cx36 and Cx50 gap channel blocker. Antimalarial, antischistosomal and antiviral.

    Purity:

    >98%

    Pack:
    100mg
    Price:
    $53
    Qty:
  3. TAT-Gap19 (HB9841)

    Description:

    Cx43 hemichannel blocker. Active in vivo.

    Purity:

    >95%

    Pack:
    1mg
    Price:
    $200
    Qty: